Keyoumars Soltani to Treatment Outcome
This is a "connection" page, showing publications Keyoumars Soltani has written about Treatment Outcome.
Connection Strength
0.029
-
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer. BMC Cancer. 2014 Jan 04; 14:5.
Score: 0.012
-
Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy. Pediatr Dermatol. 2010 Sep-Oct; 27(5):537-9.
Score: 0.009
-
Clinicopathologic challenge. Sclerodermoid graft-versus-host disease (GVHD) with lichensclerosus-like lesions. Int J Dermatol. 2008 Jul; 47(7):655-7.
Score: 0.008